Navigation Links
Novartis Drug Diovan Shows Superior Benefits

Results of a Japanese study have given drug giant Novartis AG, more reasons to smile. According to the study published in The Lancet, the company’s blood pressure// drug Diovan was observed to reduce the risks of strokes and cardiovascular events by up to 40 percent.

The study titled the Jikei Heart Study, was based on 3,000 people aged 20 to 79, with high blood pressure, ischemic heart disease or congestive heart failure. The study which was published recently in The Lancet, showed that Diovan produced a 39 percent reduction in cardiovascular events and a 40 percent cut in strokes.

The study compared Diovan when added to a conventional non-angiotensin receptor blocker (ARB) versus the non-ARB therapy alone. Accordingly, the superior benefits reported with Diovan led to an early termination of the study.

In addition to its impact on overall cardiovascular events and stroke, other benefits of Diovan demonstrated were: relative reductions of 65 percent in angina pectoris, 46 percent in heart failure and 81 percent in aortic dissection - separation of the wall layers in the body's main artery – as compared to other treatment groups.

There were few adverse events (2.5 percent overall) with no significant difference in tolerability between the groups. According to investigators, these effects were reported independently of blood pressure reductions.

Says Gordon McInnes, Professor of Medicine at the Western Infirmary in Glasgow, Scotland:"The results of this trial carry an important clinical message for physicians across the globe who are trying to protect patients from debilitating complications such as stroke. "Jikei Heart tells us that adding Diovan to usual treatment regimens can offer substantial long-term protection”, he added.

The Jikei Heart Study is the first controlled trial to assess the cardiovascular benefits of adding the angiotensin receptor blocker, or ARB, Diovan to conventional non-A
'"/>




Page: 1 2

Related medicine news :

1. Novartis files application with FDA for Zometa
2. Canine Painkiller unveiled by Novartis
3. Glivec the hot cancer drug from Novartis
4. Zometa [Novartis Drug] For Treatment Of Paget’s Diseas
5. Novartis MS Drug Shows Promising Results
6. Bird-flu Vaccine Adjuvant Contract Goes to Novartis
7. Drop Patent Petition, Activists Ask Novartis
8. E.U. Panel Backs Novartis Mock-up Pandemic Flu Vaccine
9. Indian Court Refers Novartis Plea for Patent on Anti-cancer Drug to a Separate Board
10. Novartis Gleevec Found Effective in Treating Gastro-intestinal Tumors
11. Experimental treatment for Ebola Virus Shows promising results in mice
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Novartis Drug Diovan Shows Superior Benefits

(Date:8/4/2015)... , ... August 04, 2015 , ... 24/7 Care ... Los Angeles, Riverside, and San Bernardino, today announced that the U.S. Department of Veteran’s ... that 24/7 Care At Home’s agency is well on the path to meeting the ...
(Date:8/4/2015)... ... August 04, 2015 , ... ... those entering kindergarten. All required immunizations are covered for members under the Healthchek ... children who aren’t caught up with their immunizations may not be allowed to ...
(Date:8/4/2015)... ... August 04, 2015 , ... Discovia, a leading ... announced that John Munro, a 15-year veteran of the eDiscovery services industry, has ... , “I am thrilled to join Discovia at this important point in its ...
(Date:8/4/2015)... St. Louis, Missouri (PRWEB) , ... August 04, ... ... Automated Texting (IAT) solutions, today announced that Bruce McCalley joins its executive leadership ... 30-year track record of sales success at technology companies and expanding global markets ...
(Date:8/4/2015)... ... August 04, 2015 , ... Mesothelioma ... has come back: Retreatment may be a viable option. Surviving Mesothelioma has just ... , According to surgeons at the University of New South Wales, ...
Breaking Medicine News(10 mins):Health News:24/7 Care At Home Receives Two Stars from the VA 2Health News:24/7 Care At Home Receives Two Stars from the VA 3Health News:Buckeye Health Plan Reminds Parents to Keep Immunizations In Mind As School Year Kicks Off 2Health News:John Munro Joins eDiscovery Leader Discovia as Vice President of Managed Services Operations 2Health News:John Munro Joins eDiscovery Leader Discovia as Vice President of Managed Services Operations 3Health News:SanusEO Hires Healthcare Technology Executive Bruce McCalley As Senior Vice President of Sales & Marketing 2Health News:SanusEO Hires Healthcare Technology Executive Bruce McCalley As Senior Vice President of Sales & Marketing 3Health News:New Research Reveals Some Patients Experience Extended Mesothelioma Survival with Repeat Treatment, According to Surviving Mesothelioma 2
... Function Drinks,announced today the launch of their ... on supporting sexual health. Function: Night Life ... amino acid, tyrosine, to provide,the building blocks ... with reward and desire. Epimedium, niacin and,cnidium ...
... for ... consumers, PRINCETON, N.J., June ... care products,announced today that its key product line, MEDIHONEY(TM) Wound & Burn,Dressings ... counter (OTC) sales. This will provide consumers with expanded,access to the products ...
... Kiner has,been named vice president and general manager ... In this new role, Stewart is responsible for,providing ... senior market lines of business, including Medicare Advantage ... Kiner will report to,Karen Vigil, senior vice president ...
... 24 Speaker Nancy Pelosi,issued the following statement ... Act, which passed the House this afternoon by ... bipartisan and veto-proof vote sends a strong signal ... for providers will not,be held hostage to the ...
... Zuccari,President & CEO of Hamilton Insurance Agency is featured ... Health Care Association this,June for his recent work with ... by the AHCA," said Alan J. Zuccari. "I,am proud ... focus is providing quality care.", Below is the ...
... supply, study suggests , , TUESDAY, June 24 (HealthDay News) ... help reduce a form of brain injury that affects ... study. , Hypoxic-ischemia, a compromise of the brain,s ... and cognitive/behavioral problems. , In experiments with rats that ...
Cached Medicine News:Health News:Function Drinks Launches New Product to Support Sexual Health 2Health News:Derma Sciences Receives FDA Clearance to Sell MEDIHONEY(TM) Over the Counter 2Health News:Derma Sciences Receives FDA Clearance to Sell MEDIHONEY(TM) Over the Counter 3Health News:Blue Shield of California Appoints Industry Veteran as New Vice President and General Manager for Senior Market 2Health News:Alan J. Zuccari Featured by the American Health Care Association as a June PAC Member 2Health News:Alzheimer's Drug May Reduce Preemie Brain Injury 2
(Date:8/4/2015)... -- Eli Lilly and Company (NYSE: LLY ) today ... its intent to end its contract with the university ... Alzheimer,s disease (A4) study. The A4 study is a ... of Alzheimer,s disease in older individuals who have evidence ... but do not show symptoms of memory impairment. A4 ...
(Date:8/4/2015)... , Aug. 4, 2015  IRIDEX Corporation (Nasdaq: ... Mackaness , who had served as chief financial officer ... has resigned his positions with the Company, effective August ... at another company. Mr. Mackaness intends to continue to ... quarter earnings announcement and 10-Q filing. ...
(Date:8/4/2015)... 2015 Governor Tom Wolf announced today ... and markets implants in the spine and trauma markets, will ... , Northampton County to serve as ... create 25 new, full-time jobs. "Tyber Medical,s ... create more than two dozen, high-paying jobs is great news ...
Breaking Medicine Technology:Lilly to End Contract with the University of California, San Diego for A4 Alzheimer's Study 2Lilly to End Contract with the University of California, San Diego for A4 Alzheimer's Study 3IRIDEX Chief Financial Officer Resigns to Accept Another Opportunity 2Wolf Administration Announces Tyber Medical to Establish Operations and Create New Jobs in Northampton County 2Wolf Administration Announces Tyber Medical to Establish Operations and Create New Jobs in Northampton County 3
... The Michael J. Fox Foundation awarded a total of ... pre-clinical research on potential new treatments for Parkinson,s disease.The ... Initiative. This program, first launched in 2006, supports ... is part of MJFF,s focus on ...
... Jan. 6 Pacira Pharmaceuticals, Inc., an,acute care ... completed in two pivotal Phase III SIMPLE trials ... intraoperative administration of EXPAREL(TM),(DepoBupivacaine) for prolonged postoperative analgesia. ... studies in hemorrhoidectomy and in total knee,arthroplasty (TKA) ...
Cached Medicine Technology:Michael J. Fox Foundation Awards $2.7 Million to Four Industry Teams for Pre-Clinical Parkinson's Disease Research 2Phase III Studies of EXPAREL(TM) (DepoBupivacaine) from Pacira Complete Enrollment 2Phase III Studies of EXPAREL(TM) (DepoBupivacaine) from Pacira Complete Enrollment 3
All metal for storing 5 cm x 5 cm (2 inches x 2 inches) 35 mm color slides. Each is individually crafted of high grade steel and finished with a durable baked enamel finish....
It's a slide cabinet system, store up to 54,000 slides in only 2 square feet of space. Ideal for use in Pathology, Cytology, Hematology, Histology, Dermatology, Research, Education....
A slide filing system, allows for the convenient storage and retrieval of microscope slides or transparencies. Requires only 48 cm x 48 cm (19 inches x 19 inches) of floor space....
Unit System Slide Cabinet is constructed from hardwood for long lasting....
Medicine Products: